{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T15:50:05Z","timestamp":1787068205500,"version":"build-2736575974"},"reference-count":37,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Transplantation"],"published-print":{"date-parts":[[2018,11]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Extensive data have been accumulated for adults who have undergone ABO-incompatible (ABOi)-living kidney transplantation (LKT). In contrast, available published data on pediatric recipients who underwent ABOi-LKT from the early to middle 2000s is very limited. Thus, pediatric ABOi-LKT has remained relatively rare, and there is a lack of large, multicenter data.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We analyzed data from the Japanese Kidney Transplant Registry to clarify the patient and graft outcomes of pediatric recipients who underwent ABOi-LKT from 2002 to 2015. A total of 102 ABOi and 788 ABO-compatible (ABOc) recipients were identified in this study. All recipients had received basiliximab and a triple immunosuppressive protocol comprising calcineurin inhibitors, mycophenolate mofetil, and steroids. The ABOi recipients also received preconditioning therapies including B-cell depletion by a splenectomy or rituximab treatment and therapeutic apheresis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Death rates for ABOi and ABOc recipients were 0.17 versus 0.17 deaths per 100 patient-years. Graft loss rates for ABOi and ABOc recipients were 1.58 versus 1.45 events per 100 patient-years. No particular causes of death or graft loss predominantly affected ABOi or ABOc recipients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The results of this registry analysis suggest that pediatric ABOi-LKT can be performed efficiently. Although further studies are clearly required to perform pediatric ABOi-LKT more safely and less invasively, ABOi-LKT is now an acceptable treatment for pediatric patients with end-stage renal disease.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/tp.0000000000002259","type":"journal-article","created":{"date-parts":[[2018,5,17]],"date-time":"2018-05-17T18:42:43Z","timestamp":1526582563000},"page":"1934-1942","source":"Crossref","is-referenced-by-count":24,"title":["Outcomes of Pediatric ABO-incompatible Living Kidney Transplantations From 2002 to 2015: An Analysis of the Japanese Kidney Transplant Registry"],"prefix":"10.1097","volume":"102","author":[{"given":"Motoshi","family":"Hattori","sequence":"first","affiliation":[{"name":"Department of Pediatric Nephrology, Tokyo Women\u2019s Medical University, School of Medicine, Tokyo, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makiko","family":"Mieno","sequence":"additional","affiliation":[{"name":"Department of Medical Informatics Center for Information, Jichi Medical University, Tochigi, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seiichiro","family":"Shishido","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Aikawa","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Faculty of Medicine, Toho University, Tokyo, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hidetaka","family":"Ushigome","sequence":"additional","affiliation":[{"name":"Department of Transplantation and Regenerative Surgery, Kyoto Prefectural University of Medicine, Kyoto, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinichi","family":"Ohshima","sequence":"additional","affiliation":[{"name":"National Center for Geriatrics and Gerontology, Aichi, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kota","family":"Takahashi","sequence":"additional","affiliation":[{"name":"Niigata Organ Transplant Foundation, Niigata, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Hasegawa","sequence":"additional","affiliation":[{"name":"Kamata Minami-guchi Kidney Clinic, Tokyo, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"bib1-20231002","first-page":"4538","article-title":"Present experiences in a series of 26 ABO-incompatible living donor renal allograft","volume":"19","year":"1987","journal-title":"Transplant Proc"},{"key":"bib2-20231002","first-page":"224","article-title":"Long-term results of ABO-incompatible living kidney transplantation: a single-center experience","volume":"65","year":"1998","journal-title":"Transplantation"},{"key":"bib3-20231002","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1111\/j.1600-6143.2004.00464.x","article-title":"Excellent long-term outcome of ABO-incompatible living donor kidney transplantation in Japan","volume":"4","year":"2004","journal-title":"Am J Transplant"},{"key":"bib4-20231002","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1111\/j.1600-6143.2006.01676.x","article-title":"Evaluation of immunosuppressive regimens in ABO-incompatible living kidney transplantation\u2013single center analysis","volume":"7","year":"2007","journal-title":"Am J Transplant"},{"key":"bib5-20231002","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1097\/01.TP.0000078622.43689.D4","article-title":"Successful ABO-incompatible kidney transplantations without splenectomy using antigen-specific immunoadsorption and rituximab","volume":"76","year":"2003","journal-title":"Transplantation"},{"key":"bib6-20231002","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1111\/j.1600-6143.2004.00507.x","article-title":"Plasmapheresis, CMV hyperimmune globulin, and anti-CD20 allow ABO-incompatible renal transplantation without splenectomy","volume":"4","year":"2004","journal-title":"Am J Transplant"},{"key":"bib7-20231002","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1097\/TP.0b013e318245b2af","article-title":"Outcomes of ABO-incompatible kidney transplantation in the United States","volume":"93","year":"2012","journal-title":"Transplantation"},{"key":"bib8-20231002","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1097\/TP.0000000000000312","article-title":"Three-year outcomes following 1420 ABO-incompatible living-donor kidney transplants performed after ABO antibody reduction: Results from 101 centers","volume":"99","year":"2015","journal-title":"Transplantation"},{"key":"bib9-20231002","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1093\/ndt\/gfv388","article-title":"One hundred ABO-incompatible kidney transplantations between 2004 and 2014: a single-center experience","volume":"31","year":"2016","journal-title":"Nephrol Dial Transplant"},{"key":"bib10-20231002","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1111\/ajt.13502","article-title":"ABO-incompatible living kidney transplants: evolution of outcomes and immunosuppressive management","volume":"16","year":"2016","journal-title":"Am J Transplant"},{"key":"bib11-20231002","first-page":"1","article-title":"ABO-incompatible pediatric kidney transplantation in a single-center trial","volume":"14","year":"2000","journal-title":"Pediatr Nephrol"},{"key":"bib12-20231002","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1097\/00007890-200109270-00010","article-title":"ABO-incompatible living-donor kidney transplantation in children","volume":"72","year":"2001","journal-title":"Transplantation"},{"key":"bib13-20231002","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1111\/j.1399-3089.2006.00279.x","article-title":"ABO-incompatible kidney transplantation of an 8-yr-old girl with donor\/recipient-constellation A1B\/B","volume":"13","year":"2006","journal-title":"Xenotransplantation"},{"key":"bib14-20231002","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1111\/j.1399-3046.2011.01480.x","article-title":"ABO-incompatible kidney transplantation in children","volume":"15","year":"2011","journal-title":"Pediatr Transplant"},{"key":"bib15-20231002","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/s00467-012-2302-x","article-title":"Bleeding complications in pediatric ABO-incompatible kidney transplantation","volume":"28","year":"2013","journal-title":"Pediatr Nephrol"},{"key":"bib16-20231002","first-page":"E74","article-title":"Successful ABO incompatible renal transplantation following rituximab and DFPP after failed immunoadsorption","volume":"18","year":"2014","journal-title":"Pediatr Transplant"},{"key":"bib17-20231002","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1007\/s00467-015-3064-z","article-title":"Optimizing HLA matching in a highly sensitized pediatric patient using ABO-incompatible and paired exchange kidney transplantation","volume":"30","year":"2015","journal-title":"Pediatr Nephrol"},{"key":"bib18-20231002","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1097\/TP.0000000000001325","article-title":"Immune desensitization allows pediatric blood group incompatible kidney transplantation","volume":"101","year":"2017","journal-title":"Transplantation"},{"key":"bib19-20231002","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1007\/s00467-012-2279-5","article-title":"Maximising living donation with paediatric blood-group-incompatible renal transplantation","volume":"28","year":"2013","journal-title":"Pediatr Nephrol"},{"key":"bib20-20231002","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1007\/s10157-014-0978-x","article-title":"Prevalence and incidence of chronic kidney disease stage G5 in Japan","volume":"19","year":"2015","journal-title":"Clin Exp Nephrol"},{"key":"bib21-20231002","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/s41100-016-0080-9","article-title":"Current status of kidney transplantation in Japan in 2015: the data of the Kidney Transplant Registry Committee, Japanese Society for Clinical Renal Transplantation and the Japan Society for Transplantation","volume":"2","year":"2016","journal-title":"Renal Replacement Therapy"},{"key":"bib22-20231002","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1111\/j.1432-2277.2009.00903.x","article-title":"Cytomegalovirus infection following renal transplantation in patients administered low-dose rituximab induction therapy","volume":"22","year":"2009","journal-title":"Transpl Int"},{"key":"bib23-20231002","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1097\/TP.0b013e31829df29d","article-title":"Updated international consensus guidelines on the management of cytomegalovirus in solid-organ transplantation","volume":"96","year":"2013","journal-title":"Transplantation"},{"key":"bib24-20231002","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1007\/s10157-014-1077-8","article-title":"End-stage renal disease in Japanese children: a nationwide survey during 2006-2011","volume":"19","year":"2015","journal-title":"Clin Exp Nephrol"},{"key":"bib25-20231002","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1097\/01.tp.0000296008.08452.4c","article-title":"Japanese experience of ABO-incompatible living kidney transplantation","volume":"84","year":"2007","journal-title":"Transplantation"},{"key":"bib26-20231002","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1038\/ncpneph0967","article-title":"Japan\u2019s experience with living-donor kidney transplantation across ABO barriers","volume":"4","year":"2008","journal-title":"Nat Clin Pract Nephrol"},{"key":"bib27-20231002","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1056\/NEJMra1314376","article-title":"Kidney transplantation in children","volume":"371","year":"2014","journal-title":"N Engl J Med"},{"key":"bib28-20231002","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1097\/TP.0000000000000029","article-title":"Early clinical complications after ABO-incompatible live-donor kidney transplantation: a national study of Medicare-insured recipients","volume":"98","year":"2014","journal-title":"Transplantation"},{"key":"bib29-20231002","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1097\/TP.0000000000000933","article-title":"Preconditioning therapy in ABO-incompatible living kidney transplantation: a systematic review and meta-analysis","volume":"100","year":"2016","journal-title":"Transplantation"},{"key":"bib30-20231002","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1097\/TP.0000000000000362","article-title":"A systematic review of the use of rituximab for desensitization in renal transplantation","volume":"98","year":"2014","journal-title":"Transplantation"},{"key":"bib31-20231002","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1093\/ndt\/gfw017","article-title":"The effect of rituximab dose on infectious complications in ABO-incompatible kidney transplantation","volume":"31","year":"2016","journal-title":"Nephrol Dial Transplant"},{"key":"bib32-20231002","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1111\/ajt.13052","article-title":"Rituximab as induction therapy after renal transplantation: a randomized, double-blind, placebo-controlled study of efficacy and safety","volume":"15","year":"2015","journal-title":"Am J Transplant"},{"key":"bib33-20231002","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1097\/TP.0b013e31819f2024","article-title":"ABO incompatible renal transplantation: a paradigm ready for broad implementation","volume":"87","year":"2009","journal-title":"Transplantation"},{"key":"bib34-20231002","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1097\/TP.0000000000001415","article-title":"Histological and extended clinical outcomes after ABO-incompatible renal transplantation without splenectomy or rituximab","volume":"101","year":"2017","journal-title":"Transplantation"},{"key":"bib35-20231002","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1097\/TP.0b013e31825b7608","article-title":"Distribution of ABO blood group antibody titers in pediatric patients awaiting renal transplantation: implication for organ allocation policy","volume":"94","year":"2012","journal-title":"Transplantation"},{"key":"bib36-20231002","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s00467-013-2479-7","article-title":"Therapeutic plasma exchange for the treatment of pediatric renal diseases in 2013","volume":"29","year":"2014","journal-title":"Pediatr Nephrol"},{"key":"bib37-20231002","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1093\/ndt\/gfu375","article-title":"Antibody-incompatible kidney transplantation in 2015 and beyond","volume":"30","year":"2015","journal-title":"Nephrol Dial Transplant"}],"container-title":["Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00007890-201811000-00031","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,2]],"date-time":"2023-10-02T01:01:02Z","timestamp":1696208462000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00007890-201811000-00031"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11]]},"references-count":37,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1097\/tp.0000000000002259","relation":{},"ISSN":["1534-6080","0041-1337"],"issn-type":[{"value":"1534-6080","type":"electronic"},{"value":"0041-1337","type":"print"}],"subject":[],"published":{"date-parts":[[2018,11]]}}}